CA2395006A1 - Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production - Google Patents

Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production Download PDF

Info

Publication number
CA2395006A1
CA2395006A1 CA002395006A CA2395006A CA2395006A1 CA 2395006 A1 CA2395006 A1 CA 2395006A1 CA 002395006 A CA002395006 A CA 002395006A CA 2395006 A CA2395006 A CA 2395006A CA 2395006 A1 CA2395006 A1 CA 2395006A1
Authority
CA
Canada
Prior art keywords
phenyl
bis
methylethyl
carbon atoms
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002395006A
Other languages
English (en)
French (fr)
Inventor
Reynold Homan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of CA2395006A1 publication Critical patent/CA2395006A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA002395006A 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production Abandoned CA2395006A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30933601P 2001-08-01 2001-08-01
US60/309,336 2001-08-01

Publications (1)

Publication Number Publication Date
CA2395006A1 true CA2395006A1 (en) 2003-02-01

Family

ID=23197778

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002395006A Abandoned CA2395006A1 (en) 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production

Country Status (11)

Country Link
US (1) US20030134898A1 (enExample)
EP (1) EP1281399A3 (enExample)
JP (1) JP2003104878A (enExample)
KR (1) KR20030013289A (enExample)
CN (1) CN1404829A (enExample)
CA (1) CA2395006A1 (enExample)
HU (1) HUP0202548A2 (enExample)
IL (1) IL150918A0 (enExample)
NZ (1) NZ520487A (enExample)
PL (1) PL355281A1 (enExample)
ZA (1) ZA200206032B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
BRPI0415136A (pt) * 2003-10-09 2006-11-28 Warner Lambert Co método para a diminuição da produção de sebo
JP5197016B2 (ja) 2004-12-23 2013-05-15 デシファラ ファーマスーティカルズ, エルエルシー 酵素モジュレータ及び治療
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
CA2684666A1 (en) 2007-04-20 2008-11-20 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
KR20110099687A (ko) 2008-10-29 2011-09-08 데시페라 파마슈티칼스, 엘엘씨. 항-암과 항-증식성 활성을 나타내는 시클로프로판 아미드와 유사체
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
JP2019512009A (ja) 2016-02-16 2019-05-09 ザ・ユニバーシティ・オブ・クイーンズランド スルホニルウレアおよび関連化合物ならびにこれらの利用
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
EP3746059A1 (en) 2018-01-31 2020-12-09 Deciphera Pharmaceuticals, LLC Combination therapy for the treatment of gastrointestinal stromal tumors
WO2019152719A1 (en) 2018-01-31 2019-08-08 Deciphera Pharmaceuticals, Llc Combination therapy for the treatment of mastocytosis
JP2021534148A (ja) * 2018-08-15 2021-12-09 インフレイゾーム リミテッド 新規スルフォンアミドウレア化合物
PT3983387T (pt) 2019-06-12 2024-07-10 Nodthera Ltd Derivados de sulfonilurea e seus usos
CN114615982A (zh) 2019-08-12 2022-06-10 德西费拉制药有限责任公司 用于治疗胃肠道间质瘤的瑞普替尼
WO2021030405A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
SI4084779T1 (sl) 2019-12-30 2025-02-28 Deciphera Pharmaceuticals, Llc Sestave 1-(4-bromo-5-(1-etil-7-(metilamino)-2-okso-1,2-dihidro-1,6-naftiridin-3-il)-2-fluorofenil)-3-fenil sečnine
KR20220123057A (ko) 2019-12-30 2022-09-05 데시페라 파마슈티칼스, 엘엘씨. 비정질 키나아제 억제제 제형 및 이의 사용 방법
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
US5214206A (en) * 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
US5198466A (en) * 1990-11-09 1993-03-30 Warner-Lambert Company Oxysulfonyl urea acat inhibitors
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
UA75345C2 (en) * 2000-02-02 2006-04-17 Warner Lambert Co Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition
US6514489B1 (en) * 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
US6852738B2 (en) * 2001-01-30 2005-02-08 Merck & Co., Inc. Acyl sulfamides for treatment of obesity, diabetes and lipid disorders

Also Published As

Publication number Publication date
ZA200206032B (en) 2004-02-10
HU0202548D0 (enExample) 2002-10-28
JP2003104878A (ja) 2003-04-09
CN1404829A (zh) 2003-03-26
EP1281399A2 (en) 2003-02-05
IL150918A0 (en) 2003-02-12
EP1281399A3 (en) 2004-02-11
US20030134898A1 (en) 2003-07-17
PL355281A1 (en) 2003-02-10
NZ520487A (en) 2004-03-26
HUP0202548A2 (hu) 2003-02-28
KR20030013289A (ko) 2003-02-14

Similar Documents

Publication Publication Date Title
CA2395006A1 (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
CA2087251C (en) Pharmaceutical compositions
US5252604A (en) Compositions of retinoic acids and tocopherol for prevention of dermatitis
DE69813935T2 (de) Verwendung von Retinoiden zur Induzierung von Hautpigmentierung
PL180746B1 (pl) Związki polienowe oraz zawierające je kompozycje farmaceutyczne i kosmetyczne
US20120282314A1 (en) Dermatological/cosmetic skin depigmenting compositions
JP5774004B2 (ja) ヘキサミジン類とレチノイド類を含有するニキビ改善又は治療組成物
PT1761266E (pt) Compostos, formulações, e métodos para tratamento ou prevenção de distúrbios inflamatórios da pele
US20130178446A1 (en) Method for decreasing sebum production
DE69500576T2 (de) Verwendung eines Ethylendiaminderivats in einer kosmetischen und/oder dermatologischen Zusammensetzung und Zusammensetzung, die insbesondere ein Produkt mit reizender Nebenwirkung enthaelt
AU2002306767B2 (en) Topical dapsone for the treatment of acne
EP0628308B1 (en) Use of O-esters of L-carnitine with aromatic acids for the treatment of dermatoses
US6730703B2 (en) Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
US8821904B2 (en) Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
US20130165526A1 (en) Topical treatment with dapsone in g6pd-deficient patients
US20090298868A1 (en) Quinoline compounds as melanogenesis modifiers and uses thereof
CN101563073A (zh) 奈帕芬胺或其衍生物用于治疗与可能具有炎性免疫-过敏成分的角质化紊乱有关的皮肤病的用途
US20090137569A1 (en) Administration of (3S)-N-hydroxy-4-(sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (S)-N_hydroxy-4-[4_(but-2-ynyloxy)phenylsulfonyl]-2,2-dimethyl thimomorpholine-3-carboxamide for preventing and/or treating inflammatory skin pathologies/afflictions
NZ250581A (en) (all e)-3,7-dimethyl-9-[3,5-dimethyl-2-(nonyloxy)phenyl]-2,4,6,8- nonatetraenoic acid and pharmaceutically acceptable salts and hydrolysable esters; pharmaceutical compositions
WO2021203136A1 (en) Methods for treating hyperpigmentation and compositions for same
US9822136B2 (en) Chemical inhibitors of sebocyte function
JP2013001655A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued